These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 12673668)

  • 1. Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A.
    Tsujikawa K; Dan Y; Nogawa K; Sato H; Yamada Y; Murakami H; Ohtani H; Sawada Y; Iga T
    Biopharm Drug Dispos; 2003 Apr; 24(3):105-14. PubMed ID: 12673668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
    Haraguchi K; Ito K; Kotaki H; Sawada Y; Iga T
    Drug Metab Dispos; 1997 Jun; 25(6):675-84. PubMed ID: 9193868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data.
    Hsiao P; Sasongko L; Link JM; Mankoff DA; Muzi M; Collier AC; Unadkat JD
    J Pharmacol Exp Ther; 2006 May; 317(2):704-10. PubMed ID: 16415090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro-to-in vivo prediction of P-glycoprotein-based drug interactions at the human and rodent blood-brain barrier.
    Hsiao P; Bui T; Ho RJ; Unadkat JD
    Drug Metab Dispos; 2008 Mar; 36(3):481-4. PubMed ID: 18057117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
    Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in mice.
    Nasu R; Matsuo H; Takanaga H; Ohtani H; Sawada Y
    Biopharm Drug Dispos; 2000 May; 21(4):129-38. PubMed ID: 11180191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of domperidone into the rat brain is increased by brain ischaemia or treatment with the P-glycoprotein inhibitor verapamil.
    Dan Y; Murakami H; Koyabu N; Ohtani H; Sawada Y
    J Pharm Pharmacol; 2002 May; 54(5):729-33. PubMed ID: 12005368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study.
    Tsai PL; Tsai TH
    Planta Med; 2004 Nov; 70(11):1069-74. PubMed ID: 15549664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein-mediated efflux of phenobarbital at the blood-brain barrier evidence from transport experiments in vitro.
    Yang ZH; Liu XD
    Epilepsy Res; 2008 Jan; 78(1):40-9. PubMed ID: 18063342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of P-glycoprotein activity at the primate blood-brain barrier increases the distribution of nelfinavir into the brain but not into the cerebrospinal fluid.
    Kaddoumi A; Choi SU; Kinman L; Whittington D; Tsai CC; Ho RJ; Anderson BD; Unadkat JD
    Drug Metab Dispos; 2007 Sep; 35(9):1459-62. PubMed ID: 17591677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier.
    Ejsing TB; Linnet K
    Hum Psychopharmacol; 2005 Mar; 20(2):149-53. PubMed ID: 15624117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in blood-brain barrier permeability to drugs in decompressed rats.
    Kaakkola S; Lehtosalo J; Laitinen LA
    Undersea Biomed Res; 1982 Sep; 9(3):233-40. PubMed ID: 6890252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically.
    Ishiwata K; Kawamura K; Yanai K; Hendrikse NH
    J Nucl Med; 2007 Jan; 48(1):81-7. PubMed ID: 17204702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of nitric oxide on fentanyl and haloperidol-induced catalepsy in mice.
    Erkent U; Iskit AB; Onur R; Ilhan M
    Eur J Anaesthesiol; 2006 Jul; 23(7):580-5. PubMed ID: 16507184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein inhibition potentiates the behavioural and neurochemical actions of risperidone in rats.
    Pacchioni AM; Gabriele A; Donovan JL; DeVane CL; See RE
    Int J Neuropsychopharmacol; 2010 Sep; 13(8):1067-77. PubMed ID: 19835667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin.
    Zong J; Pollack GM
    J Pharmacol Exp Ther; 2003 Aug; 306(2):556-62. PubMed ID: 12721332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of p-glycoprotein inhibitor combinations on drug efflux from rat brain microvessel endothelial cells.
    Yang ZY; Liu GQ
    Pharmazie; 2004 Dec; 59(12):952-6. PubMed ID: 15638085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
    Egashira N; Matsuda T; Koushi E; Mishima K; Iwasaki K; Shoyama Y; Fujiwara M
    Eur J Pharmacol; 2006 Nov; 550(1-3):117-22. PubMed ID: 17022969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.